>Европейский рынок лечения расстройств сна по типу (бессонница, апноэ во сне, синдром беспокойных ног (СБН), нарколепсия и другие), лечение (фармакологическая терапия, механическая терапия, устройства для выдвижения нижней челюсти, стимулятор подъязычного нерва, хирургия и другие), способ введения (пероральный, парентеральный и другие), тип лекарств (брендовые и дженерики), тип населения (дети и взрослые), конечный пользователь (больницы, специализированные клиники, домашняя медицинская помощь, амбулаторный хирургический центр и другие), канал сбыта (прямой тендер, больничная аптека, розничная аптека, интернет-аптека и другие), страна (Великобритания, Германия, Франция, Венгрия, Литва, Австрия, Ирландия, Норвегия, Польша, Турция, Испания, Италия, Нидерланды, Швейцария, Россия и остальная Европа) Тенденции отрасли и прогноз до 2028 года
Анализ рынка и информация: рынок лечения расстройств сна в Европе
Ожидается, что рынок лечения расстройств сна будет расти в прогнозируемый период с 2021 по 2028 год. По данным Data Bridge Market Research, рынок растет со среднегодовым темпом роста 7,6% в прогнозируемый период с 2021 по 2028 год и, как ожидается, достигнет 2 849,03 млн долларов США к 2028 году. Ожидается, что рынок лечения расстройств сна в Европе будет расти из-за возросшей распространенности таких расстройств сна, как апноэ во сне, бессонница и нарколепсия во всем мире.
Расстройства сна, такие как апноэ сна , нарколепсия или бессонница, являются медицинскими расстройствами, при которых у пациента возникают трудности с поддержанием сна или засыпанием. Это расстройство вызывает нерегулярные умственные, физические, социальные и эмоциональные функции. Расстройства сна лечатся различными методами в зависимости от симптомов пациентов. Большинство пациентов с апноэ сна лечатся с помощью механических методов лечения.
Рост расстройств сна увеличит спрос на варианты лечения расстройств сна. Таким образом, ожидается, что увеличение психического стресса из-за беспокойного образа жизни и нездоровых привычек будет способствовать росту рынка лечения расстройств сна. Степень побочных эффектов может быть опасной для жизни, вызывая страх перед потреблением у пациентов, что приводит к снижению продаж и спроса. Таким образом, побочные эффекты лекарств выступают в качестве сдерживающего фактора для роста рынка лечения расстройств сна. Растущий технологический прогресс выступает в качестве возможности для повышения спроса на рынке лечения расстройств сна. Высокая стоимость лечения расстройств сна выступает в качестве проблемы для роста рынка лечения расстройств сна.
Отчет о рынке лечения расстройств сна содержит подробную информацию о доле рынка, новых разработках и анализе продуктового портфеля, влиянии внутренних и локальных игроков рынка, анализирует возможности с точки зрения новых источников дохода, изменений в рыночных правилах, одобрений продуктов, стратегических решений, запусков продуктов, географических расширений и технологических инноваций на рынке. Чтобы понять анализ и сценарий рынка лечения расстройств сна, свяжитесь с Data Bridge Market Research для получения аналитического обзора, наша команда поможет вам создать решение по влиянию на доход для достижения желаемой цели.
Масштаб и размер рынка лечения расстройств сна
Рынок лечения расстройств сна подразделяется на семь заметных сегментов, которые основаны на типе, лечении, пути введения, типе лекарств, типе населения, конечном пользователе и канале распространения. Рост среди сегментов помогает вам анализировать нишевые карманы роста и стратегии для выхода на рынок и определять ваши основные области применения и разницу в ваших целевых рынках.
- По типу рынок лечения расстройств сна сегментируется на бессонницу , апноэ во сне, синдром беспокойных ног (СБН), нарколепсию и другие. Ожидается, что в 2021 году сегмент бессонницы будет доминировать на рынке лечения расстройств сна из-за технологического прогресса в целях разработки инновационных вариантов лечения конкретного расстройства.
- На основе лечения рынок лечения расстройств сна сегментируется на фармакологическую терапию, механическую терапию, устройства для выдвижения нижней челюсти, стимулятор подъязычного нерва, хирургию и др. Ожидается, что в 2021 году сегмент фармакологической терапии будет доминировать на рынке лечения расстройств сна, поскольку для лечения расстройств сна в соответствии с симптомами пациентов доступны многочисленные классы лекарств.
- На основе пути введения рынок лечения расстройств сна сегментируется на пероральный, парентеральный и другие. Ожидается, что в 2021 году пероральный сегмент будет доминировать на рынке лечения расстройств сна из-за возросшей доступности пероральных препаратов для лечения расстройств сна, таких как нарколепсия, синдром беспокойных ног (СБН) и бессонница среди других.
- На основе типа лекарств рынок лечения расстройств сна сегментируется на брендовые и дженерики. Ожидается, что в 2021 году сегмент дженериков будет доминировать на рынке лечения расстройств сна из-за возросшей доступности дженериков для лечения расстройств сна, таких как Габапентин, Таблетки Золпидем ER и Таблетки Эсзопиклон, CIV и другие.
- На основе типа населения рынок лечения расстройств сна сегментируется на детский и взрослый. Ожидается, что в 2021 году сегмент взрослых будет доминировать на рынке лечения расстройств сна из-за растущего гериатрического населения по всему миру, которому требуются более продвинутые варианты лечения.
- On the basis of end user, the sleep disorder treatment market is segmented into hospitals, specialty clinics, home healthcare, ambulatory surgical center and others. In 2021, hospitals segment is expected to dominate the sleep disorder treatment market due to the financial capabilities of hospitals to purchase expensive equipment used in surgery along with the presence of trained professionals to operate the mechanical devices and prescribed medications.
- On the basis of distribution channel, the sleep disorder treatment market is segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others. In 2021, direct tender segment is expected to dominate the sleep disorder treatment market as most of the drugs are procured through direct tender services.
Sleep Disorder Treatment Market Country Level Analysis
The sleep disorder treatment market is analysed and market size information is provided by the country, type, treatment, route of administration, drugs type, population type, end user and distribution channel as referenced above.
The countries covered in the Europe sleep disorder treatment market report are U.K., Germany, France, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Turkey, Spain, Italy, Netherlands, Switzerland, Russia and Rest of Europe.
- In Europe sleep disorder treatment market, Germany is dominating the market due to the rising prevalence of sleeping disorders and growing geriatric population in the country is augmenting the sleep disorder treatment market.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Europe brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
New Product Launches by Manufacturers is creating new opportunities for Players in the Sleep Disorder Treatment Market
The sleep disorder treatment market also provides you with detailed market analysis for every country growth in aesthetic industry with sleep disorder treatment market sales, impact of advancement in the sleep disorder treatment market and changes in regulatory scenarios with their support for the sleep disorder treatment market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Sleep Disorder Treatment Market Share Analysis
Конкурентная среда рынка лечения расстройств сна содержит сведения по конкурентам. Включены сведения о компании, финансы компании, полученный доход, рыночный потенциал, инвестиции в исследования и разработки, новые рыночные инициативы, производственные площадки и объекты, сильные и слабые стороны компании, запуск продукта, испытания продуктов, одобрения продуктов, патенты, ширина и широта продукта, доминирование приложений, кривая жизненной линии технологий. Приведенные выше данные относятся только к фокусу компании, связанному с рынком лечения расстройств сна.
Основными игроками, рассматриваемыми в отчете на рынке лечения расстройств сна, являются Jazz Pharmaceuticals, Inc., Pfizer Inc., Viatris Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Taj Pharmaceuticals Limited, Eli Lilly and Company, Mallinckrodt, Alembic Pharmaceuticals Limited, Dr. Reddy's Laboratories Ltd., Taro Pharmaceutical Industries Ltd., Koninklijke Philips NV, DeVilbiss Healthcare LLC, ResMed и SomnoMed среди других отечественных игроков. Аналитики DBMR понимают конкурентные преимущества и предоставляют конкурентный анализ для каждого конкурента отдельно.
Многие запуски продуктов и соглашения также инициируются компаниями по всему миру, что также ускоряет развитие рынка лечения расстройств сна.
Например,
- В ноябре 2019 года компания Pfizer, Inc. объявила, что ее подразделение Upjohn объединяется с Mylan NV и образует новую компанию Viatris. Это объединение бизнес-подразделения компании с Mylan NV увеличило ее продуктовый портфель, что привело к увеличению спроса на ее продукцию на рынке.
Сотрудничество, совместные предприятия и другие стратегии участников рынка расширяют возможности компании на рынке лечения расстройств сна, что также дает организациям возможность улучшить свои предложения по лечению расстройств сна.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE SLEEP DISORDER TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
5 EUROPE SLEEP DISORDER TREATMENT MARKET: REGULATIONS
6 EUROPE SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 RISING PREVALENCE OF SLEEPING DISORDERS
7.1.2 RISE IN THE GERIATRIC POPULATION
7.1.3 INCREASE IN MENTAL STRESS DUE TO HECTIC LIFE & UNHEALTHY HABITS
7.1.4 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS
7.1.5 PRESENCE OF POTENTIAL CLINICAL PIPELINE CANDIDATES
7.2 RESTRAINTS
7.2.1 SIDE EFFECTS ASSOCIATED WITH THESE DRUGS
7.2.2 PATENT EXPIRATION OF MAJOR SLEEP DISORDER TREATMENT DRUGS
7.2.3 EMERGENCE OF GENERICS
7.3 OPPORTUNITIES
7.3.1 TECHNOLOGICAL ADVANCEMENTS IN THE SLEEP AIDS
7.3.2 INCREASING USAGE OF SOCIAL MEDIA AND GROWING ADDICTION OF GADGETS SUCH AS SMARTPHONES AND LAPTOPS
7.3.3 GROWING AWARENESS ABOUT TARGET DISEASE
7.4 CHALLENGES
7.4.1 HIGH COST OF DIAGNOSIS & TREATMENT FOR SLEEPING DISORDER
7.4.2 STRINGENT REGULATORY LANDSCAPE
7.4.3 POTENTIAL ILL-EFFECTS DUE TO DRUG ABUSE
8 IMPACT OF COVID-19 ON EUROPE SLEEP DISORDER TREATMENT MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES BY MARKET PLAYERS DURING COVID-19
8.5 CONCLUSION
9 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE
9.1 OVERVIEW
9.2 INSOMNIA
9.2.1 INSOMNIA
9.2.2 CHILD INSOMNIA
9.2.3 OTHERS
9.3 SLEEP APNEA
9.3.1 OBSTRUCTIVE SLEEP APNEA
9.3.2 CENTRAL SLEEP APNEA
9.3.3 SNORING
9.3.4 INFANT SLEEP APNEA
9.3.5 OTHERS
9.4 RESTLESS LEGS SYNDROME (RLS)
9.5 NARCOLEPSY
9.5.1 TYPE 1
9.5.2 TYPE 2
10 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT
10.1 OVERVIEW
10.2 PHARMACOLOGICAL THERAPY
10.2.1 CANNABIDIOL
10.2.2 ANTI-PARKINSONIAN DRUGS (DOPAMINE AGONISTS)
10.2.3 BENZODIAZEPINES
10.2.4 NON-BENZODIAZEPINE
10.2.5 MELATONIN RECEPTOR STIMULATOR
10.2.6 STIMULANTS
10.2.7 SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) OR SEROTONIN AND NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS)
10.2.8 TRICYCLIC ANTIDEPRESSANTS
10.2.9 SODIUM OXYBATE (XYREM)
10.2.10 OTHERS
10.3 MECHANICAL THERAPY
10.3.1 CPAP (CONTINUOUS POSITIVE AIRWAY PRESSURE)
10.3.2 BI-LEVEL PAP
10.3.3 AUTO CPAP OR AUTO BI-LEVEL PAP
10.3.4 ADAPTIVE SERVO-VENTILATION (ASV)
10.4 MANDIBULAR ADVANCEMENT DEVICES
10.5 HYPOGLOSSAL NERVE STIMULATOR
10.6 SURGERY
10.6.1 SOMNOPLASTY
10.6.2 TONSILLECTOMY
10.6.3 NASAL SURGERY
10.6.4 OTHERS
10.7 OTHERS
11 EUROPE SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION
11.1 OVERVIEW
11.2 ORAL
11.2.1 TABLET
11.2.2 PILLS
11.2.3 OTHERS
11.3 PARENTERAL
11.4 OTHERS
12 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE
12.1 OVERVIEW
12.2 GENERICS
12.3 BRANDED
12.3.1 XYREM
12.3.2 EFFEXOR XR
12.3.3 AMBIEN
12.3.4 PRISTIQ
12.3.5 ZENZEDI
12.3.6 VYVANSE
12.3.7 OTHERS
13 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE
13.1 OVERVIEW
13.2 ADULT
13.3 CHILDREN
14 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER
14.1 OVERVIEW
14.2 HOSPITALS
14.3 SPECIALTY CLINICS
14.4 HOME HEALTHCARE
14.5 AMBULATORY SURGICAL CENTER
14.6 OTHERS
15 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 DIRECT TENDER
15.3 HOSPITAL PHARMACY
15.4 RETAIL PHARMACY
15.5 ONLINE PHARMACY
15.6 OTHERS
16 EUROPE SLEEP DISORDER TREATMENT MARKET, BY GEOGRAPHY
16.1 EUROPE
16.1.1 GERMANY
16.1.2 FRANCE
16.1.3 U.K.
16.1.4 ITALY
16.1.5 SPAIN
16.1.6 RUSSIA
16.1.7 IRELAND
16.1.8 NORWAY
16.1.9 POLAND
16.1.10 TURKEY
16.1.11 HUNGARY
16.1.12 AUSTRIA
16.1.13 LITHUANIA
16.1.14 NETHERLANDS
16.1.15 SWITZERLAND
16.1.16 REST OF EUROPE
17 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: EUROPE
18 SWOT ANALYSIS
19 COMPANY PROFILE
19.1 JAZZ PHARMACEUTICALS, INC.
19.1.1 COMPANY SNAPSHOT
19.1.2 REVENUE ANALYSIS
19.1.3 COMPANY SHARE ANALYSIS
19.1.4 PRODUCT PORTFOLIO
19.1.5 RECENT DEVELOPMENTS
19.2 PFIZER INC.
19.2.1 COMPANY SNAPSHOT
19.2.2 REVENUE ANALYSIS
19.2.3 COMPANY SHARE ANALYSIS
19.2.4 PRODUCT PORTFOLIO
19.2.5 RECENT DEVELOPMENT
19.3 ELI LILLY AND COMPANY
19.3.1 COMPANY SNAPSHOT
19.3.2 REVENUE ANALYSIS
19.3.3 COMPANY SHARE ANALYSIS
19.3.4 PRODUCT PORTFOLIO
19.3.5 RECENT DEVELOPMENTS
19.4 VIATRIS INC.
19.4.1 COMPANY SNAPSHOT
19.4.2 REVENUE ANALYSIS
19.4.3 COMPANY SHARE ANALYSIS
19.4.4 PRODUCT PORTFOLIO
19.4.5 RECENT DEVELOPMENTS
19.5 RESMED
19.5.1 COMPANY SNAPSHOT
19.5.2 REVENUE ANALYSIS
19.5.3 PRODUCT PORTFOLIO
19.5.4 RECENT DEVELOPMENTS
19.6 MALLINCKRODT
19.6.1 COMPANY SNAPSHOT
19.6.2 REVENUE ANALYSIS
19.6.3 PRODUCT PORTFOLIO
19.6.4 RECENT DEVELOPMENT
19.7 KONINKLIJKE PHILIPS N.V.
19.7.1 COMPANY SNAPSHOT
19.7.2 REVENUE ANALYSIS
19.7.3 PRODUCT PORTFOLIO
19.7.4 RECENT DEVELOPMENTS
19.8 ALEMBIC PHARMACEUTICALS LIMITED
19.8.1 COMPANY SNAPSHOT
19.8.2 REVENUE ANALYSIS
19.8.3 PRODUCT PORTFOLIO
19.8.4 RECENT DEVELOPMENT
19.9 AMNEAL PHARMACEUTICALS LLC
19.9.1 COMPANY SNAPSHOT
19.9.2 REVENUE ANALYSIS
19.9.3 PRODUCT PORTFOLIO
19.9.4 RECENT DEVELOPMENTS
19.1 APOTEX INC.
19.10.1 COMPANY SNAPSHOT
19.10.2 PRODUCT PORTFOLIO
19.10.3 RECENT DEVELOPMENT
19.11 ARBOR PHARMACEUTICALS
19.11.1 COMPANY SNAPSHOT
19.11.2 PRODUCT PORTFOLIO
19.11.3 RECENT DEVELOPMENTS
19.12 AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
19.12.1 COMPANY SNAPSHOT
19.12.2 REVENUE ANALYSIS
19.12.3 PRODUCT PORTFOLIO
19.12.4 RECENT DEVELOPMENTS
19.13 BMC MEDICAL CO.
19.13.1 COMPANY SNAPSHOT
19.13.2 PRODUCT PORTFOLIO
19.13.3 RECENT DEVELOPMENT
19.14 DEVILBISS HEALTHCARE LLC
19.14.1 COMPANY SNAPSHOT
19.14.2 PRODUCT PORTFOLIO
19.14.3 RECENT DEVELOPMENT
19.15 DR. REDDY’S LABORATORIES LTD.
19.15.1 COMPANY SNAPSHOT
19.15.2 REVENUE ANALYSIS
19.15.3 PRODUCT PORTFOLIO
19.15.4 RECENT DEVELOPMENT
19.16 HIKMA PHARMACEUTICALS PLC
19.16.1 COMPANY SNAPSHOT
19.16.2 REVENUE ANALYSIS
19.16.3 PRODUCT PORTFOLIO
19.16.4 RECENT DEVELOPMENTS
19.17 LUPIN PHARMACEUTICALS, INC. (A SUBSIDIARY OF LUPIN)
19.17.1 COMPANY SNAPSHOT
19.17.2 REVENUE ANALYSIS
19.17.3 PRODUCT PORTFOLIO
19.17.4 RECENT DEVELOPMENTS
19.18 OVENTUS
19.18.1 COMPANY SNAPSHOT
19.18.2 REVENUE ANALYSIS
19.18.3 PRODUCT PORTFOLIO
19.18.4 RECENT DEVELOPMENTS
19.19 SANOFI-AVENTIS U.S. LLC (A SUBSIDIARY OF SANOFI)
19.19.1 COMPANY SNAPSHOT
19.19.2 REVENUE ANALYSIS
19.19.3 PRODUCT PORTFOLIO
19.19.4 RECENT DEVELOPMENTS
19.2 SOMNOMED
19.20.1 COMPANY SNAPSHOT
19.20.2 REVENUE ANALYSIS
19.20.3 PRODUCT PORTFOLIO
19.20.4 RECENT DEVELOPMENTS
19.21 TAJ PHARMACEUTICALS LIMITED
19.21.1 COMPANY SNAPSHOT
19.21.2 PRODUCT PORTFOLIO
19.21.3 RECENT DEVELOPMENT
19.22 TARO PHARMACEUTICAL INDUSTRIES LTD.
19.22.1 COMPANY SNAPSHOT
19.22.2 REVENUE ANALYSIS
19.22.3 PRODUCT PORTFOLIO
19.22.4 RECENT DEVELOPMENT
19.23 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
19.23.1 COMPANY SNAPSHOT
19.23.2 REVENUE ANALYSIS
19.23.3 PRODUCT PORTFOLIO
19.23.4 RECENT DEVELOPMENTS
20 QUESTIONNAIRE
21 RELATED REPORTS
Список таблиц
LIST OF TABLES
TABLE 1 EUROPE SLEEP DISORDER TREATMENT MARKET: PIPELINE ANALYSIS
TABLE 2 GENERIC DRUGS FOR SLEEP DISORDER TREATMENT
TABLE 3 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 4 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2018-2028 (USD MILLION)
TABLE 5 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 6 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 7 EUROPE SLEEP SPNEA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 8 EUROPE RESTLESS LEGS SYNDROME (RLS) IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 9 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 10 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 11 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT, 2018-2028 (USD MILLION)
TABLE 12 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 13 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 14 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 15 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 16 EUROPE MANDIBULAR ADVANCEMENT DEVICES IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 17 EUROPE HYPOGLOSSAL NERVE STIMULATOR IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 18 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 19 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 20 EUROPE OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 21 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 22 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 23 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 24 EUROPE PARENTERAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 25 EUROPE OTHERS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 26 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 27 EUROPE GENERICS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 28 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 29 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 30 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE, 2018-2028 (USD MILLION)
TABLE 31 EUROPE ADULT IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 32 EUROPE CHILDREN IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 33 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER, 2018-2028 (USD MILLION)
TABLE 34 EUROPE HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 35 EUROPE SPECIALTY CLINICS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 36 EUROPE HOME HEALTHCARE IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 37 EUROPE AMBULATORY SURGICAL CENTER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 38 EUROPE OTHERS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 39 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL, 2018-2028 (USD MILLION)
TABLE 40 EUROPE DIRECT TENDER IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 41 EUROPE HOSPITAL PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 42 EUROPE RETAIL PHARMACY IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 43 EUROPE ONLINE PHARMACY IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 44 EUROPE HOSPITALS IN SLEEP DISORDER TREATMENT MARKET, BY TYPE 2019-2028 (USD MILLION) BY REGION
TABLE 45 EUROPE SLEEP DISORDER TREATMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 46 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 EUROPE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 EUROPE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 49 EUROPE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 50 EUROPE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 51 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 52 EUROPE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 53 EUROPE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 54 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 55 EUROPE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 56 EUROPE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 57 EUROPE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 58 EUROPE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 59 EUROPE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 60 EUROPE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 61 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 62 GERMANY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 63 GERMANY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 64 GERMANY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 65 GERMANY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 66 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 67 GERMANY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 68 GERMANY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 69 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 70 GERMANY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 71 GERMANY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 72 GERMANY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 73 GERMANY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 74 GERMANY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 75 GERMANY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 76 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 77 FRANCE INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 FRANCE SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 79 FRANCE NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 80 FRANCE SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 81 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 82 FRANCE MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 83 FRANCE SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 84 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 85 FRANCE ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 86 FRANCE PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 87 FRANCE BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 88 FRANCE SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 89 FRANCE SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 90 FRANCE SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 91 U.K. SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 U.K. INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 93 U.K. SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 94 U.K. NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 95 U.K. SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 96 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 97 U.K. MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 98 U.K. SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 99 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 100 U.K. ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 101 U.K. PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 102 U.K. BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 103 U.K. SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 104 U.K. SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 105 U.K. SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 106 ITALY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 107 ITALY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 108 ITALY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 109 ITALY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 110 ITALY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 111 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 112 ITALY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 113 ITALY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 114 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 115 ITALY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 116 ITALY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 117 ITALY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 118 ITALY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 119 ITALY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 120 ITALY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 121 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 122 SPAIN INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 123 SPAIN SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 124 SPAIN NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 125 SPAIN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 126 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 127 SPAIN MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 128 SPAIN SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 129 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 130 SPAIN ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 131 SPAIN PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 132 SPAIN BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 133 SPAIN SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 134 SPAIN SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 135 SPAIN SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 136 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 RUSSIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 138 RUSSIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 139 RUSSIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 140 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 141 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 142 RUSSIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 143 RUSSIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 144 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 145 RUSSIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 146 RUSSIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 147 RUSSIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 148 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 149 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 150 RUSSIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 151 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 152 IRELAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 153 IRELAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 154 IRELAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 155 IRELAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 156 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 157 IRELAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 158 IRELAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 159 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 160 IRELAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 161 IRELAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 162 IRELAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 163 IRELAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 164 IRELAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 165 IRELAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 166 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 167 NORWAY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 168 NORWAY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 169 NORWAY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 170 NORWAY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 171 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 172 NORWAY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 173 NORWAY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 174 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 175 NORWAY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 176 NORWAY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 177 NORWAY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 178 NORWAY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 179 NORWAY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 180 NORWAY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 181 POLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 182 POLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 183 POLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 184 POLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 185 POLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 186 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 187 POLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 188 POLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 189 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 190 POLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 191 POLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 192 POLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 193 POLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 194 POLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 195 POLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 196 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 197 TURKEY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 198 TURKEY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 199 TURKEY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 200 TURKEY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 201 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 202 TURKEY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 203 TURKEY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 204 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 205 TURKEY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 206 TURKEY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 207 TURKEY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 208 TURKEY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 209 TURKEY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 210 TURKEY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 211 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 212 HUNGARY INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 213 HUNGARY SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 214 HUNGARY NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 215 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 216 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 217 HUNGARY MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 218 HUNGARY SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 219 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 220 HUNGARY ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 221 HUNGARY PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 222 HUNGARY BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 223 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 224 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 225 HUNGARY SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 226 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 227 AUSTRIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 228 AUSTRIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 229 AUSTRIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 230 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 231 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 232 AUSTRIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 233 AUSTRIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 234 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 235 AUSTRIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 236 AUSTRIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 237 AUSTRIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 238 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 239 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 240 AUSTRIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 241 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 242 LITHUANIA INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 243 LITHUANIA SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 244 LITHUANIA NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 245 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 246 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 247 LITHUANIA MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 248 LITHUANIA SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 249 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 250 LITHUANIA ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 251 LITHUANIA PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 252 LITHUANIA BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 253 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 254 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 255 LITHUANIA SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 256 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 257 NETHERLANDS INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 258 NETHERLANDS SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 259 NETHERLANDS NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 260 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 261 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 262 NETHERLANDS MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 263 NETHERLANDS SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 264 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 265 NETHERLANDS ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 266 NETHERLANDS PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 267 NETHERLANDS BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 268 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 269 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 270 NETHERLANDS SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 271 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 272 SWITZERLAND INSOMNIA IN SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 273 SWITZERLAND SLEEP APNEA IN SLEEP DISORDER TREATMENT MARKET , BY TYPE 2020-2028 (USD MILLION)
TABLE 274 SWITZERLAND NARCOLEPSY IN SLEEP DISORDER TREATMENT MARKET ,2020-2028 (USD MILLION)
TABLE 275 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 276 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 277 SWITZERLAND MECHANICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 278 SWITZERLAND SURGERY IN SLEEP DISORDER TREATMENT MARKET, BY TREATMENT 2020-2028 (USD MILLION)
TABLE 279 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 280 SWITZERLAND ORAL PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 2020-2028 (USD MILLION)
TABLE 281 SWITZERLAND PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 282 SWITZERLAND BRANDED PHARMACOLOGICAL THERAPY IN SLEEP DISORDER TREATMENT MARKET, BY DRUGS TYPE 2020-2028 (USD MILLION)
TABLE 283 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY POPULATION TYPE 2020-2028 (USD MILLION)
TABLE 284 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY END USER 2020-2028 (USD MILLION)
TABLE 285 SWITZERLAND SLEEP DISORDER TREATMENT MARKET, BY DISTRIBUTION CHANNEL 2020-2028 (USD MILLION)
TABLE 286 REST OF EUROPE SLEEP DISORDER TREATMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
Список рисунков
LIST OF FIGURES
FIGURE 1 EUROPE SLEEP DISORDER TREATMENT MARKET: SEGMENTATION
FIGURE 2 EUROPE SLEEP DISORDER TREATMENT MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE SLEEP DISORDER TREATMENT MARKET: DROC ANALYSIS
FIGURE 4 EUROPE SLEEP DISORDER TREATMENT MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE SLEEP DISORDER TREATMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE SLEEP DISORDER TREATMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE SLEEP DISORDER TREATMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE SLEEP DISORDER TREATMENT MARKET: MARKET END USER COVERAGE GRID
FIGURE 10 EUROPE SLEEP DISORDER TREATMENT MARKET: SEGMENTATION
FIGURE 11 RISING PREVALENCE OF SLEEPING DISORDERS IS EXPECTED TO DRIVE THE EUROPE SLEEP DISORDER TREATMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 INSOMNIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE SLEEP DISORDER TREATMENT MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE SLEEP DISORDER TREATMENT MARKET
FIGURE 14 PROPORTION OF AMERICAN TWEENS (8- TO 12- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)
FIGURE 15 PROPORTION OF AMERICAN TEENS (13- TO 18- YEAR-OLD) SPENDING TIME WITH SCREEN MEDIA IN A DAY (IN HOURS)
FIGURE 16 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020
FIGURE 17 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 18 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, CAGR (2020-2028)
FIGURE 19 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 20 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020
FIGURE 21 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, 2020-2028 (USD MILLION)
FIGURE 22 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, CAGR (2020-2028)
FIGURE 23 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TREATMENT, LIFELINE CURVE
FIGURE 24 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020
FIGURE 25 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, 2020-2028 (USD MILLION)
FIGURE 26 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2020-2028)
FIGURE 27 EUROPE SLEEP DISORDER TREATMENT MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 28 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020
FIGURE 29 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, 2020-2028 (USD MILLION)
FIGURE 30 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, CAGR (2020-2028)
FIGURE 31 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DRUGS TYPE, LIFELINE CURVE
FIGURE 32 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020
FIGURE 33 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, 2020-2028 (USD MILLION)
FIGURE 34 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, CAGR (2020-2028)
FIGURE 35 EUROPE SLEEP DISORDER TREATMENT MARKET: BY POPULATION TYPE, LIFELINE CURVE
FIGURE 36 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020
FIGURE 37 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 38 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, CAGR (2020-2028)
FIGURE 39 EUROPE SLEEP DISORDER TREATMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 40 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 42 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2028)
FIGURE 43 EUROPE SLEEP DISORDER TREATMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 EUROPE SLEEP DISORDER TREATMENT MARKET: SNAPSHOT (2020)
FIGURE 45 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020)
FIGURE 46 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 47 EUROPE SLEEP DISORDER TREATMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 EUROPE SLEEP DISORDER TREATMENT MARKET: BY TYPE (2020-2028)
FIGURE 49 EUROPE SLEEP DISORDER TREATMENT MARKET: COMPANY SHARE 2020 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
